Michael Matheny

Novel treatments for fake patients

A customizable framework uses simulated patients to distinguish effects of a new treatment from “learning effects” for clinicians; it should help identify training opportunities and hasten treatment improvements.

The study could suggest ways to promote the transport of phospholipids and cholesterol out of macrophages, immune system cells that play key roles in all stages of atherosclerosis development.

Reminders for clinicians improve prescribing for high cholesterol

A Vanderbilt study found that automated targeted reminders for clinicians helped increase prescribing of high intensity statins for patients with various atherosclerotic cardiovascular disease diagnoses, including coronary or peripheral artery disease and ischemic stroke.

Machine learning aids injury prevention in cardiac cath labs

Model students: improving clinical decision-making

Vanderbilt investigators have devised a system to alert health IT teams to deteriorating performance in clinical prediction models.

Clinical investigation society lauds Vanderbilt scientists

Five faculty members of Vanderbilt University School of Medicine are among 80 physician-scientists who will be inducted this year into the American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. They are:

AI’s Future Potential Hinges on Consensus: NAM Report

The current explosion of investment and development in health care AI is happening without an underpinning of consensus of responsible, transparent deployment, which potentially constrains its potential.